[
  {
    "ts": null,
    "headline": "Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025",
    "summary": "CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), cytomegalovirus ...",
    "url": "https://finnhub.io/api/news?id=25da756cbbab9182cacc503e1d8c49bc13570b54c207e3966a879c79cc8dadaf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744023600,
      "headline": "Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025",
      "id": 133740130,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), cytomegalovirus ...",
      "url": "https://finnhub.io/api/news?id=25da756cbbab9182cacc503e1d8c49bc13570b54c207e3966a879c79cc8dadaf"
    }
  },
  {
    "ts": null,
    "headline": "Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4",
    "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United Therapeutics (NASDAQ:UTHR).",
    "url": "https://finnhub.io/api/news?id=922a7fed6ecec9fae98a03a43b28da7c8701769aba7ee86f5b515f84f347e991",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744017091,
      "headline": "Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4",
      "id": 133738849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United Therapeutics (NASDAQ:UTHR).",
      "url": "https://finnhub.io/api/news?id=922a7fed6ecec9fae98a03a43b28da7c8701769aba7ee86f5b515f84f347e991"
    }
  }
]